A state of the art in analytical quality-by-design and perspectives in characterization of nano-enabled medicinal products

Quality-by-Design (QbD) guidance is a risk-based and proactive approach to drug development proposed in the early 2000s and now widely used in the pharmaceutical field in compliance with the ICH Q8-Q11 guidelines. Analytical Quality by Design (AQbD), introduced in 2010, is the adaptation of the QbD...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of pharmaceutical and biomedical analysis 2022-09, Vol.219, p.114911-114911, Article 114911
Hauptverfasser:	Bastogne, Thierry, Caputo, Fanny, Prina-Mello, Adriele, Borgos, Sven, Barberi-Heyob, Muriel
Format:	Artikel
Sprache:	eng
Schlagworte:	Analytical Quality-by-Design Applications Engineering Sciences Life Sciences Medication Micro and nanotechnologies Microelectronics Nanomedicine Nanoparticle Pharmaceutical sciences Physico-Chemical Characterization Statistics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!